A pan-cancer analysis of ABI3BP: a potential biomarker for prognosis and immunoinfiltration.

Frontiers in oncology(2023)

引用 0|浏览0
暂无评分
摘要
Our results show that ABI3BP might be employed as a molecular biomarker to predict prognosis, treatment susceptibility, and immunological response in patients with pan-cancer.
更多
查看译文
关键词
abi3bp,potential biomarker,prognosis,pan-cancer
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要